Public Employees Retirement System of Ohio purchased a new stake in shares of Billiontoone, Inc. (NASDAQ:BLLN – Free Report) during the 1st quarter, HoldingsChannel.com reports. The firm purchased 19,499 shares of the company’s stock, valued at approximately $1,539,000.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Rossby Financial LCC bought a new position in shares of Billiontoone in the fourth quarter valued at approximately $25,000. Wells Fargo & Company MN purchased a new stake in Billiontoone in the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC bought a new position in Billiontoone in the 4th quarter valued at $80,000. Nano Cap New Millennium Growth Fund L P purchased a new position in shares of Billiontoone during the 4th quarter valued at $82,000. Finally, Renaissance Capital LLC bought a new position in shares of Billiontoone in the fourth quarter worth $201,000.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on BLLN. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. BTIG Research reduced their target price on Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Guggenheim started coverage on Billiontoone in a research note on Monday, June 29th. They issued a “buy” rating and a $125.00 target price on the stock. Finally, JPMorgan Chase & Co. lifted their price target on Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Six equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $126.00.
Insider Buying and Selling at Billiontoone
In related news, insider Nancy Joann Johnson sold 10,582 shares of Billiontoone stock in a transaction on Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total value of $1,063,173.54. Following the transaction, the insider owned 21,900 shares in the company, valued at $2,200,293. This trade represents a 32.58% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Oguzhan Atay sold 26,250 shares of the company’s stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $122.05, for a total transaction of $3,203,812.50. Following the sale, the chief executive officer owned 20,000 shares of the company’s stock, valued at approximately $2,441,000. The trade was a 56.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 153,049 shares of company stock valued at $16,768,021. 50.22% of the stock is owned by insiders.
Billiontoone Stock Performance
Shares of BLLN stock opened at $138.60 on Monday. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. The business has a 50-day moving average price of $113.36 and a two-hundred day moving average price of $93.25. Billiontoone, Inc. has a 12-month low of $61.96 and a 12-month high of $140.21. The firm has a market cap of $6.37 billion and a P/E ratio of 252.00.
Billiontoone (NASDAQ:BLLN – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.01 by $0.33. The firm had revenue of $108.39 million for the quarter, compared to the consensus estimate of $95.81 million. Billiontoone’s revenue for the quarter was up 83.8% compared to the same quarter last year. During the same quarter last year, the company posted ($0.39) earnings per share. Equities analysts anticipate that Billiontoone, Inc. will post 0.92 EPS for the current fiscal year.
Billiontoone Company Profile
BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.
BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.
Read More
- Five stocks we like better than Billiontoone
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Want to see what other hedge funds are holding BLLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Billiontoone, Inc. (NASDAQ:BLLN – Free Report).
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
